| Study | Group | Total patients () | Perioperative adverse events, (%) | Postprocedure GERD, (%) |
| Wang et al., 2015 | SM | 46 | Bleeding, 7 (15.2); perforation, 6 (13.0); pneumothorax, 14 (30.4); pneumoperitoneum, 12 (26.1); and emphysema, 17 (37.0) | Symptoms or endoscopy, 7 (15.2) | Li et al., 2018 | SM | 63 | Mucosal injury, 4 (6.3); pneumoperitoneum, 2 (3.2); and fever (°C), 6 (9.5) | Symptoms, 6 (9.5); endoscopy, 6 (9.5) | LM | 63 | Mucosal injury, 5 (7.9); pneumothorax, 1 (1.6); pneumoperitoneum, 3 (4.8); pneumomediastinum, 1 (1.6); subcutaneous emphysema, 24 (38.1); and fever (°C), 7 (11.1) | Symptoms, 8 (12.7); endoscopy, 8 (12.7) | Huang et al., 2020 | SM | 36 | Major bleeding, 2 (5.6); pneumothorax, 1 (2.8) | Symptoms, 3 (8.3); endoscopy, 1 (2.8) | LM | 74 | Major bleeding, 3 (4.1); pneumothorax, 2 (2.7); and mucosal perforation, 1 (1.4) | Symptoms, 11 (14.9); endoscopy, 6 (8.1) | Gu et al., 2020 | SM | 46 | None | Symptoms, 7 (15.2); endoscopy, 4 (8.7); and pH, 11 (23.9) | LM | 48 | Mucosal injuries, 1 (2.08) | Symptoms, 11 (22.9); endoscopy, 7 (14.6); and pH, 21 (43.8) | Nabi et al., 2020 | SM | 34 | Subcutaneous emphysema, 4 (11.76); capnoperitoneum requiring decompression, 3 (8.82); retroperitoneal CO2, 4 (11.76); minor bleeding episodes, 12 (35.29); and mucosal injuries requiring clipping, 1 (2.94) | Endoscopy, 11 (32.4); pH, 7 (25.92) | LM | 37 | Subcutaneous emphysema, 4 (11.76); capnoperitoneum requiring decompression, 3 (8.10); retroperitoneal CO 2, 2 (5.40); minor bleeding episodes, 17 (45.94); mucosal injuries requiring clipping, 1 (2.70) | Endoscopy, 18 (48.6); pH, 12 (40.00) |
|
|